ストックスクリーナーアプリを入手
13.82
0.95%
0.13
前日終値:
$13.69
開ける：
$13.72
24時間の取引高:
8,380
Relative Volume:
0.08
時価総額：
$287.69M
収益：
$306.91M
当期純損益:
$-59.11M
株価収益率:
-92.13
EPS:
-0.15
ネットキャッシュフロー:
$6.35M
1週間 パフォーマンス:
-0.97%
1か月 パフォーマンス:
-16.44%
6か月 パフォーマンス:
-17.00%
1年 パフォーマンス:
+25.64%
1日の値動き範囲:
$13.72
$14.00
1週間の範囲:
$13.12
$14.33
52週間の値動き範囲:
$7.08
$20.90
Amarin Corp Adr Stock (AMRN) Company Profile
名前
Amarin Corp Adr
セクター
電話
353 1 6699 020
住所
SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2
AMRN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AMRN
Amarin Corp Adr
|
13.84 | 284.65M | 306.91M | -59.11M | 6.35M | -0.15 |
|
LLY
Lilly Eli Co
|
1,106.00 | 952.34B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.44 | 493.40B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
228.90 | 395.77B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
MRK
Merck Co Inc
|
110.91 | 270.22B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
NVS
Novartis Ag Adr
|
142.35 | 272.99B | 54.45B | 14.42B | 17.15B | 7.333 |
Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-20 | 再開されました | JP Morgan | Underweight |
| 2023-10-25 | ダウングレード | Jefferies | Buy → Hold |
| 2023-01-06 | アップグレード | Jefferies | Hold → Buy |
| 2022-05-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-05-05 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-05-05 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-04 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2021-05-12 | ダウングレード | Goldman | Neutral → Sell |
| 2020-09-29 | 再開されました | JP Morgan | Neutral |
| 2020-08-26 | 開始されました | Piper Sandler | Overweight |
| 2020-05-05 | 開始されました | Northland Capital | Outperform |
| 2020-03-31 | ダウングレード | Goldman | Buy → Neutral |
| 2020-03-31 | ダウングレード | Jefferies | Buy → Hold |
| 2020-03-31 | アップグレード | Oppenheimer | Underperform → Perform |
| 2020-03-13 | アップグレード | Goldman | Neutral → Buy |
| 2020-03-02 | 開始されました | Cowen | Outperform |
| 2020-02-18 | アップグレード | Citigroup | Neutral → Buy |
| 2020-01-06 | 開始されました | JP Morgan | Neutral |
| 2019-12-16 | ダウングレード | Stifel | Buy → Hold |
| 2019-11-20 | 開始されました | Oppenheimer | Underperform |
| 2019-11-18 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-11-15 | 繰り返されました | SVB Leerink | Outperform |
| 2019-10-31 | 開始されました | Aegis Capital | Buy |
| 2019-10-15 | 開始されました | Goldman | Neutral |
| 2019-08-14 | 開始されました | SVB Leerink | Outperform |
| 2019-07-09 | 繰り返されました | Jefferies | Buy |
| 2019-06-17 | 開始されました | ROTH Capital | Buy |
| 2019-03-22 | 開始されました | Stifel | Buy |
すべてを表示
Amarin Corp Adr (AMRN) 最新ニュース
China Universal Asset Management Co. Ltd. Sells 76,302 Shares of Amarin Corporation PLC $AMRN - Defense World
Net current asset value per share of Amarin Corporation Plc Sponsored ADR – MUN:EH3 - TradingView — Track All Markets
Companies Like Amarin (NASDAQ:AMRN) Are In A Position To Invest In Growth - Sahm
Tops & Flops Stocks - sharewise.com
RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +10.7%; ISTURISA PEAK SALES ESTIMATE DOUBLED TO GREATER THAN € 1.2 BILLION - GlobeNewswire Inc.
Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes - Sahm
Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - ADVFN
Cash from operating activities of Amarin Corporation Plc Sponsored ADR – SWB:EH3 - TradingView
Amarin Corporation plc (NASDAQ:AMRN) Stock Catapults 25% Though Its Price And Business Still Lag The Industry - Sahm
Amarin Corporation plc Announces $17.8 Million Registered Direct Offering of American Depositary Shares - ADVFN
Amarin stock rises after ESC Congress data on VASCEPA mechanism - Investing.com
Earnings call transcript: Amarin Q2 2025 sees revenue beat, stock stable - Investing.com
Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Barchart.com
Amarin Gears Up To Report Q2 Earnings: Here's What To Expect - Barchart.com
VKTX Stock Down On Wider-Than-Expected Loss In Q2, Nil Sales - Barchart.com
Zacks.com featured highlights include Mama's Creations, Bassett Furniture Industries and Amarin - Barchart.com
3 Strong Buy Breakout Stocks for Explosive Returns - The Globe and Mail
FDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV Pill - Finviz
KRYS Begins Dosing With Gene Therapy In Rare Eye Disease, Stock Up - Barchart.com
RYTM Stock Rises On Upbeat Acquired Hypothalamic Obesity Study Data - Barchart.com
PROK Surges More Than 500% On Upbeat Data From Kidney Cell Therapy Study - Barchart.com
PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy Study - Finviz
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance
Amarin stock jumps after $25 million licensing deal with Recordati - Investing.com
Incyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma - Finviz
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
SNY's Rilzabrutinib Wins 4th Orphan Drug Tag for Sickle Cell Disease - Finviz
Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance
VSTM Stock Soars 22% in a Month on Ovarian Cancer Combo Drug Approval - Finviz
SpringWorks Gets CHMP Nod For Mirdametinib In Rare Disease - Barchart.com
Amarin earnings beat by $0.04, revenue topped estimates - Investing.com
Amarin Corp PLC Share Price ADR Each Rep 20 Ord Spon - Hargreaves Lansdown
Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com
Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com
Amarin announces board member departure ahead of annual meeting - Investing.com
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView
Amarin urged to review strategy by major shareholders - Investing.com
The Market Doesn't Like What It Sees From Amarin Corporation plc's (NASDAQ:AMRN) Revenues Yet As Shares Tumble 26% - Sahm
Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance
Amarin Announces 1-for-20 Reverse Stock Split - TipRanks
Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com
Amarin granted extension to meet Nasdaq listing standards - Investing.com
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Amarin to present new cardiovascular research at ESC Congress - Investing.com
China approves VASCEPA to reduce cardiovascular risk - Investing.com
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Investing.com UK
Amarin's VAZKEPA gains reimbursement approval in Greece - Investing.com
Amarin secures new patent for heart drug VAZKEPA in Europe - Investing.com
Free float of Amarin Corporation Plc Sponsored ADR – NASDAQ:AMRN - TradingView
symbol__ Stock Quote Price and Forecast - CNN
Sarissa Capital Calls for Amarin Special Meeting to Vote on Its Nominees - 24/7 Wall St.
Amarin Corp Adr (AMRN) 財務データ
収益
当期純利益
現金流量
EPS
0.20%
0.93%
大文字化:
|
ボリューム (24 時間):